Table 2.

Central foveal thickness (CFT) prior to treatment and at follow-up intervals.

Patient	Baseline	Day 7	Mo. 1	Mo. 2	Mo. 4	Mo. 6	Mo. 8	Mo. 12
1	563	349	349	346	345	339	340	346
2	438	381	266	256	250	255	251	248
3§	852	361	221	220	—	—	—	—
4§	707	395	223	215	260	470	—	—
5	658	263	254	201	213	213	210	215
6*	630	312	279	266	295	309	250	369
7*	424	297	269	289	268	277	250	261
8*	808	397	270	263	278	280	273	268
9*	610	369	302	289	285	298	281	303
10*	526	331	305	289	290	293	282	249
Mean	621.6	345.5	273.8	263.4	276	303.8	267.1	282.4
Median	620	355	269.5	264.5	278	293	262	264.5
SD	142.2	44.3	38.5	43.4	36.0	71.5	37.5	52.7
Range	424–852	263–397	221–349	201–346	213–345	213–470	210–340	215–369
P value†		0.005	0.005	0.005	0.008	0.008	0.012	0.012
Delta‡		−276	−348	−358	−346	−318	−354	−339

^*Patients denoted with ∗ had a second implant at month 7.

^§Patients dropped out from the study.

^† P value refers to Wilcoxon signed-rank test on the median values with respect to the baseline.

^‡Delta denotes the mean difference with the baseline.

Mo.: month.